Inovio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $65 | $116 |
Gross Profit | -749 | -741 | 65 | -658 |
EBITDA | -44,747 | -22,777 | -25,050,529 | -18,605 |
EBIT | -45,496 | -23,519 | -25,051,272 | -19,381 |
Net Income | -45,496 | -23,519 | -19,694 | -19,381 |
Net Change In Cash | 0 | 0 | 65 | 116 |
Free Cash Flow | -21,641 | -20,811,359 | -26,933 | -19,663 |
Cash | 36,567 | 24,351 | 39,915 | 65,813 |
Basic Shares | 52,169 | 38,830 | 27,160 | 27,160 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $217 | $832 | $10,262 | $1,774 |
Gross Profit | -2,912 | 832 | 10,262 | 1,774 |
EBITDA | -103,946 | -130,391 | -270,902 | -296,557 |
EBIT | -107,076 | -133,894 | -276,398 | -301,287 |
Net Income | -107,254 | -135,117 | -279,818 | -303,658 |
Net Change In Cash | 217 | 832 | 10,262 | 1,774 |
Cost of Revenue | -24,788 | -179,554 | ||
Free Cash Flow | -104,564 | -124,686 | -217,184 | -216,939 |
Cash | 65,813 | 14,310 | 46,329 | 71,143 |
Basic Shares | 27,160 | 22,173 | 19,885 | 214,622 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.87 |
2025-06-30 | -$0.61 |
2025-03-31 | -$0.51 |
2024-12-31 | -$0.60 |
